… BRAFV600E mutation both in patients submitted to RAI nor in those treated more conservatively.
Conclusions: The somatic BRAFV600E mutation … risk factor for disease persistence. …

… Hashimoto's thyroiditis and BRAF V600E mutation status in patients with papillary thyroid
cancer (PTC) and to determine their combined association with tumor aggressiveness in PTC. …

… tumor DNA (ctDNA) in primary papillary thyroid cancer (PTC) is yet to be well established.
This study aimed to clarify whether ctDNA carrying the BRAF V600E mutation in … primary tumor …

… BRAF V600E mutation is not associated with recurrence. Recent studies have indicated that
the effect of the BRAF V600E mutation … including age, sex, tumor size, and multifocality [21,…

… Kaplan-Meier analysis of the impact of BRAF V600E mutation on disease recurrence–free
survival of patients with solitary intrathyroidal conventional papillary thyroid cancer. A) Tumors …

… , thyroid capsular invasion in 83 (78.3%) and extrathyroid extension in 73 (68.9%). Among
the 95 patients with available BRAF V600E mutation data, the BRAF V600E mutation was …

… As far as presence of BRAF V600E mutation was correlated with intratumor infiltration by …
with BRAF V600E mutation appearance. Surprisingly the rate of BRAF V600E mutation …

… cancer-facts-figures-2013 , last accessed July 14, 2015). Given that the number of deaths
attributable to papillary thyroid cancer … as a result of their thyroid cancer. Distinguishing those …

… up-to-date overview concerning possible roles of BRAF V600E mutation in PTC. As a result,
we found that BRAF V600E mutation analysis not only improved the diagnostic accuracy of …

… However, the role of BMI is unclear in papillary thyroid cancer (PTC). The aim of the present
… between BMI and BRAF V600E mutation status in PTC. BRAF V600E mutation in 108 …